Cover Image

Federal R&D, Drug Discovery, and Pricing : Insights from the NIH-University-Industry Relationship.

Explores reasons behind Government funding of R&D and subsequent efforts to facilitate private sector commercialization of the results of such work. Examines the manner in which NIH supports research to encourage the development of new pharmaceuticals and therapeutics through cooperative activit...

Full description

Bibliographic Details
Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 2008.
Series:	U.S. Congressional Research.
Subjects:	Medicine > Research. Pharmaceutical industry. Price regulation. Electronic books.
Online Access:	Connect to the full text of this electronic book

Similar Items

Federal R&D, Drug Discovery, and Pricing : Insights from the NIH-University-Industry Relationship.
Published: (2009)

Federal R&D, Drug Discovery, and Pricing : Insights from NIH-University-Industry Relationship.
Published: (2006)

Federal Drug Price Negotiation : Implications for Medicare Part D.
Published: (2007)

Federal Drug Price Negotiation : Implications for Medicare Part D.
Published: (2007)

Biotechnology, Breakthrough Drugs, and Health Care Reform : Lessons from the NIH-University-Industry Relationship.
Published: (1994)

Federal R&D, Drug Discovery, and Pricing : Insights from the NIH-University-Industry Relationship.
Published: (2007)

Federal R&D, Drug Discovery, and Pricing : Insights from NIH-University-Industry Relationship.
Published: (2004)

Prescription drug pricing in the private sector.
Published: (2007)

Pharmaceutical Costs : A Comparison of Department of Veterans Affairs (VA), Medicaid, and Medicare Policies.
Published: (2007)

Pharmaceutical Costs : A Comparison of Department of Veterans Affairs (VA), Medicaid, and Medicare Policies.
Published: (2007)

Pricing a new drug /
by: Munshaw, Supriya, et al.
Published: (2019)

Public Health Clinic Prudent Pharmaceutical Purchasing Act.
Published: (1992)

Pricing of drugs, 1977 : joint hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources and the Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary, United States Senate, 95th Congress, first session ... July 14, 1977.
Published: (1977)

Entry threats and pricing in the generic drug industry /
by: Wendling, Brett
Published: (2010)

Pharmaceutical price regulation : public perceptions, economic realities, and empirical evidence /
by: Vernon, John A.
Published: (2008)

Orphan Drug Act : Background and Proposed Legislation in the 107th Congress.
Published: (2001)

The politics of the international pricing of prescription drugs /
by: Harrison, Christopher Scott
Published: (2004)

Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993.
Published: (1993)

Drug pricing investigation : majority staff report /
Published: (2021)

HIV/AIDS Drugs, Patents and the TRIPS Agreement : Issues and Options.
Published: (2001)

Prescription drug price increases : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985.
Published: (1986)

Measuring prescription drug prices : a primer on the CPI Prescription Drug Index /
Published: (2019)

Essays on price theory and industrial organization /
by: Bain, Joe S. (Joe Staten), 1912-1991
Published: (1972)

International transfer pricing in the ethical pharmaceutical industry.
by: Wündisch, Karl
Published: (2003)

Federal R&D, Drug Discovery, and Pricing : Insights from the NIH-University-Industry Relationship.
Published: (2000)

Prescription Drug Importation : How S. 242/H.R. 380 Would Change Current Law.
Published: (2007)

Ensuring That Drugs Prescribed to Children Are Safe and Effective.
Published: (2007)

Drug pricing investigation: AbbVie : Humira and Imbruvica : staff report /
Published: (2021)

Drug topics red book.
Published: (1992)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

Health Care Reform and Investment in New Drug Development.
Published: (1995)

Unsustainable drug prices : hearing before the Committee on Oversight and Reform, House of Representatives.
Published: (2020)

The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1993.
Published: (1993)

Public attitudes toward prescription costs and the drug industry : a report /
Published: (1955)

Complete accounts of integrated drug discovery and development : recent examples from the pharmaceutical industry /
Published: (2018)

Federal Taxation of the Pharmaceutical Industry and New Drug Development.
Published: (2004)

Market power and price levels in the ethical drug industry /
by: Walker, Hugh D., 1938-
Published: (1971)

Chronicles of drug discovery /
Published: (1982)

Prescription Drug Pricing in the Private Sector : CBO Paper.
Published: (2007)